Current Affairs

GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

(MedPage Today)-The cognitive performance was not different among four categories of drugs that reduce glucose for type 2 diabetes, and data from the clinical trial. The cognitive performance was in 4.1 years of follow -up similar in the participants …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button